Funding for this research was provided by:
National Key Research and Development Program of China (2018YFA0108003)
National Science Foundation for Young Scientists of China (81901094)
Article History
Received: 29 March 2024
Accepted: 28 August 2024
First Online: 11 September 2024
Declarations
:
: Human iPSC/iPSC-derived NSCs were purchased from IxCell Biotechnology, Ltd. The study entitled “Peripheral Blood Mononuclear Cells-Derived Neural Stem Cells” was approved on 11/10/2016 by Tongji University School of Medicine Review Board (reference number EC.D(BG)0.016.01.1). All patients gave written informed consent.
: No applicable.
: All authors reported no biomedical financial interests or potential conflicts of interest.